Showing results (341-350 of 649) with videos related to

Sort By:
Pageof 65
Hemasphere|January 24, 2025
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromesDavid Rombaut, Sarah Sandmann, Tobias Tekath, et al.
Hemasphere|January 17, 2025
Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanismNathan Dubois, David Van Morckhoven, Laurentijn Tilleman, et al.
Hemasphere|January 17, 2025
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter studyMaximilian Merz, Anca-Maria Albici, Bastian von Tresckow, et al.
Hemasphere|January 14, 2025
Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphomaSophia Stock, Veit L Bücklein, Viktoria Blumenberg, et al.
Hemasphere|March 25, 2025
Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed-methods, prospective cohort studyElisabeth Dovern, Sterre J A M Nijland, Annemarie M J Braamse, et al.
Hemasphere|December 19, 2024
Inflammatory pathways and anti-inflammatory therapies in sickle cell diseaseKarina Tozatto-Maio, Felipe A Rós, Ricardo Weinlich, et al.
Hemasphere|December 2, 2024
Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteersMichela Asperti, Andrea Denardo, Magdalena Gryzik, et al.
Hemasphere|December 3, 2024
Cerebral hemodynamics and oxygen metabolism in patients with milder and severe forms of sickle cell disease and thalassemiaLiza Afzali-Hashemi, Koen P A Baas, Anouk Schrantee, et al.
Hemasphere|December 12, 2024
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experienceVeronica González-Calle, Paula Rodriguez-Otero, Maria J Calasanz, et al.
Hemasphere|November 20, 2024
A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cellsLaura Volta, Renier Myburgh, Mara Hofstetter, et al.
Pageof 65